Literature DB >> 25261504

Agreement between TOAST and CCS ischemic stroke classification: the NINDS SiGN study.

Patrick F McArdle, Steven J Kittner, Hakan Ay, Robert D Brown, James F Meschia, Tatjana Rundek, Sylvia Wassertheil-Smoller, Daniel Woo, Gunnar Andsberg, Alessandro Biffi, David A Brenner, John W Cole, Roderick Corriveau, Paul I W de Bakker, Hossein Delavaran, Martin Dichgans, Raji P Grewal, Katrina Gwinn, Mohammed Huq, Christina Jern, Jordi Jimenez-Conde, Katarina Jood, Robert C Kaplan, Petra Katschnig, Michael Katsnelson, Daniel L Labovitz, Robin Lemmens, Linxin Li, Arne Lindgren, Hugh S Markus, Leema R Peddareddygari, Annie Pedersén, Joanna Pera, Petra Redfors, Jaume Roquer, Jonathan Rosand, Natalia S Rost, Peter M Rothwell, Ralph L Sacco, Pankaj Sharma, Agnieszka Slowik, Cathie Sudlow, Vincent Thijs, Steffen Tiedt, Raffaella Valenti, Bradford B Worrall.   

Abstract

OBJECTIVE: The objective of this study was to assess the level of agreement between stroke subtype classifications made using the Trial of Org 10172 Acute Stroke Treatment (TOAST) and Causative Classification of Stroke (CCS) systems.
METHODS: Study subjects included 13,596 adult men and women accrued from 20 US and European genetic research centers participating in the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Genetics Network (SiGN). All cases had independently classified TOAST and CCS stroke subtypes. Kappa statistics were calculated for the 5 major ischemic stroke subtypes common to both systems.
RESULTS: The overall agreement between TOAST and CCS was moderate (agreement rate, 70%; κ = 0.59, 95% confidence interval [CI] 0.58-0.60). Agreement varied widely across study sites, ranging from 28% to 90%. Agreement on specific subtypes was highest for large-artery atherosclerosis (κ = 0.71, 95% CI 0.69-0.73) and lowest for small-artery occlusion (κ = 0.56, 95% CI 0.54-0.58).
CONCLUSION: Agreement between TOAST and CCS diagnoses was moderate. Caution is warranted when comparing or combining results based on the 2 systems. Replication of study results, for example, genome-wide association studies, should utilize phenotypes determined by the same classification system, ideally applied in the same manner.
© 2014 American Academy of Neurology.

Entities:  

Mesh:

Year:  2014        PMID: 25261504      PMCID: PMC4223086          DOI: 10.1212/WNL.0000000000000942

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  The Causative Classification of Stroke system: an international reliability and optimization study.

Authors:  E M Arsava; E Ballabio; T Benner; J W Cole; M P Delgado-Martinez; M Dichgans; F Fazekas; K L Furie; K Illoh; K Jood; S Kittner; A G Lindgren; J J Majersik; M J Macleod; W J Meurer; J Montaner; A A Olugbodi; A Pasdar; P Redfors; R Schmidt; P Sharma; A B Singhal; A G Sorensen; C Sudlow; V Thijs; B B Worrall; J Rosand; H Ay
Journal:  Neurology       Date:  2010-10-05       Impact factor: 9.910

2.  Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes.

Authors:  James F Meschia; Donna K Arnett; Hakan Ay; Robert D Brown; Oscar R Benavente; John W Cole; Paul I W de Bakker; Martin Dichgans; Kimberly F Doheny; Myriam Fornage; Raji P Grewal; Katrina Gwinn; Christina Jern; Jordi Jimenez Conde; Julie A Johnson; Katarina Jood; Cathy C Laurie; Jin-Moo Lee; Arne Lindgren; Hugh S Markus; Patrick F McArdle; Leslie A McClure; Braxton D Mitchell; Reinhold Schmidt; Kathryn M Rexrode; Stephen S Rich; Jonathan Rosand; Peter M Rothwell; Tatjana Rundek; Ralph L Sacco; Pankaj Sharma; Alan R Shuldiner; Agnieszka Slowik; Sylvia Wassertheil-Smoller; Cathie Sudlow; Vincent N S Thijs; Daniel Woo; Bradford B Worrall; Ona Wu; Steven J Kittner
Journal:  Stroke       Date:  2013-09-10       Impact factor: 7.914

3.  Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke study.

Authors:  Michael Marnane; Caroline A Duggan; Orla C Sheehan; Aine Merwick; Niamh Hannon; Denis Curtin; Dawn Harris; Emma B Williams; Gillian Horgan; Lorraine Kyne; Patricia M E McCormack; Joseph Duggan; Alan Moore; Gloria Crispino-O'Connell; Peter J Kelly
Journal:  Stroke       Date:  2010-07-01       Impact factor: 7.914

4.  Stroke subtyping for genetic association studies? A comparison of the CCS and TOAST classifications.

Authors:  Silvia Lanfranconi; Hugh S Markus
Journal:  Int J Stroke       Date:  2012-04-22       Impact factor: 5.266

5.  Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.

Authors:  L B Goldstein; M R Jones; D B Matchar; L J Edwards; J Hoff; V Chilukuri; S B Armstrong; R D Horner
Journal:  Stroke       Date:  2001-05       Impact factor: 7.914

6.  Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators.

Authors:  D L Gordon; B H Bendixen; H P Adams; W Clarke; L J Kappelle; R F Woolson
Journal:  Neurology       Date:  1993-05       Impact factor: 9.910

7.  Interobserver agreement in the classification of stroke in the Women's Health Study.

Authors:  Monika Atiya; Tobias Kurth; Klaus Berger; Julie E Buring; Carlos S Kase
Journal:  Stroke       Date:  2003-02       Impact factor: 7.914

Review 8.  Finding the missing heritability of complex diseases.

Authors:  Teri A Manolio; Francis S Collins; Nancy J Cox; David B Goldstein; Lucia A Hindorff; David J Hunter; Mark I McCarthy; Erin M Ramos; Lon R Cardon; Aravinda Chakravarti; Judy H Cho; Alan E Guttmacher; Augustine Kong; Leonid Kruglyak; Elaine Mardis; Charles N Rotimi; Montgomery Slatkin; David Valle; Alice S Whittemore; Michael Boehnke; Andrew G Clark; Evan E Eichler; Greg Gibson; Jonathan L Haines; Trudy F C Mackay; Steven A McCarroll; Peter M Visscher
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

9.  Interobserver agreement in the trial of org 10172 in acute stroke treatment classification of stroke based on retrospective medical record review.

Authors:  James F Meschia; Kevin M Barrett; Felix Chukwudelunzu; W Mark Brown; L Douglas Case; Brett M Kissela; Robert D Brown; Thomas G Brott; Tammy S Olson; Stephen S Rich; Scott Silliman; Bradford B Worrall
Journal:  J Stroke Cerebrovasc Dis       Date:  2006 Nov-Dec       Impact factor: 2.136

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  19 in total

1.  Etiologic stroke subtypes: updated definition and efficient workup strategies.

Authors:  Prachi Mehndiratta; Sherita Chapman Smith; Bradford B Worrall
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-01

2.  Alpha-1 antitrypsin dysfunction and large artery stroke.

Authors:  James F Meschia
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

Review 3.  Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa.

Authors:  Rufus O Akinyemi; Mayowa O Owolabi; Masafumi Ihara; Albertino Damasceno; Adesola Ogunniyi; Catherine Dotchin; Stella-Maria Paddick; Julius Ogeng'o; Richard Walker; Raj N Kalaria
Journal:  Brain Res Bull       Date:  2018-05-25       Impact factor: 4.077

Review 4.  Current advances in ischemic stroke research and therapies.

Authors:  Derek Barthels; Hiranmoy Das
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-15       Impact factor: 5.187

5.  Polygenic Risk for Depression Increases Risk of Ischemic Stroke: From the Stroke Genetics Network Study.

Authors:  Sylvia Wassertheil-Smoller; Qibin Qi; Tushar Dave; Braxton D Mitchell; Rebecca D Jackson; Simin Liu; Ki Park; Joel Salinas; Erin C Dunn; Enrique C Leira; Huichun Xu; Kathleen Ryan; Jordan W Smoller
Journal:  Stroke       Date:  2018-02-08       Impact factor: 7.914

6.  Can neuroimaging differentiate PFO and AF-related cardioembolic stroke from the other embolic sources? Clinical-radiological correlation on a retrospective study.

Authors:  Alessandro Stecco; Martina Quagliozzi; Eleonora Soligo; Andrea Naldi; Alessia Cassarà; Lorenzo Coppo; Roberta Rosso; Angelo Sante Bongo; Paola Amatuzzo; Francesco Buemi; Elena Guenzi; Alessandro Carriero
Journal:  Radiol Med       Date:  2017-02-21       Impact factor: 3.469

7.  Perivascular Fat Density and Contrast Plaque Enhancement: Does a Correlation Exist?

Authors:  L Saba; S Zucca; A Gupta; G Micheletti; J S Suri; A Balestrieri; M Porcu; P Crivelli; G Lanzino; Y Qi; V Nardi; G Faa; R Montisci
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

8.  Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study.

Authors: 
Journal:  Lancet Neurol       Date:  2015-12-19       Impact factor: 44.182

9.  GISCOME - Genetics of Ischaemic Stroke Functional Outcome network: A protocol for an international multicentre genetic association study.

Authors:  Jane M Maguire; Steve Bevan; Tara M Stanne; Erik Lorenzen; Israel Fernandez-Cadenas; Graeme J Hankey; Jordi Jimenez-Conde; Katarina Jood; Jin-Moo Lee; Robin Lemmens; Christopher Levi; Bo Norrving; Kristiina Rannikmae; Natalia Rost; Jonathan Rosand; Peter M Rothwell; Rodney Scott; Daniel Strbian; Jonathan Sturm; Cathie Sudlow; Matthew Traylor; Vincent Thijs; Turgut Tatlisumak; Tadeusz Wieloch; Daniel Woo; Bradford B Worrall; Christina Jern; Arne Lindgren
Journal:  Eur Stroke J       Date:  2017-04-19

10.  Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke.

Authors:  Christopher D Anderson; Steven A Lubitz; Shaan Khurshid; Ludovic Trinquart; Lu-Chen Weng; Olivia L Hulme; Wyliena Guan; Darae Ko; Kristin Schwab; Natalia S Rost; Mostafa A Al-Alusi; Emelia J Benjamin; Patrick T Ellinor
Journal:  Stroke       Date:  2020-04-07       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.